ERTAPENEM FOR INJECTION Poudre pour solution

Country: Kanada

Lingwa: Franċiż

Sors: Health Canada

Ingredjent attiv:

Ertapénem (Ertapénem sodique)

Disponibbli minn:

JUNO PHARMACEUTICALS CORP.

Kodiċi ATC:

J01DH03

INN (Isem Internazzjonali):

ERTAPENEM

Dożaġġ:

1G

Għamla farmaċewtika:

Poudre pour solution

Kompożizzjoni:

Ertapénem (Ertapénem sodique) 1G

Rotta amministrattiva:

Intramusculaire

Unitajiet fil-pakkett:

15G/50G

Tip ta 'preskrizzjoni:

Prescription

Żona terapewtika:

CARBAPENEMS

Sommarju tal-prodott:

Numéro de groupe d'ingrédients actifs (GIA) :0149104002; AHFS:

L-istatus ta 'awtorizzazzjoni:

APPROUVÉ

Data ta 'l-awtorizzazzjoni:

2020-05-06

Karatteristiċi tal-prodott

PM-Ertapenem-FR
Pg. 1
(U
SpQHP SRULQMHF LRQ
3
H
GH
7DEOHGHV PDLqUHV
37,( ,(16(,*1(
(176 328 /(32)(66,211(/( /
6
17e
5(16(,*1(0(1766200 ,5(6 685/( 3528,7
,1,
7,216(786
*(
/,1,48(
2175( ,1,7,216
0,6(6(1* 5 ( (7 35e87,216
())(76 ,1e6,5 %/(6
,17(5
7,216 0e ,
0(17(86(6
3262/2*,( (7
0,1,6757,21
685 26*(
02 (¶7,21(7 3+ 502/2*,(
/,1,48(
67%,/,7e (7(175(326
*(
)250(63262/2*,48(6
20326,7,21 (7
21 ,7,211(0(17
37,( ,,
(16(,*1((176 6,(17,),48(6
5(16(,*1(0(176 3+50
(87,48(6
e78(6
/,1,48(6
3+502/2*,(
e7,//e(
0,
52%,2/2*,(
72;,
2/2*,(
5e)e5(1(6
(16(,*1((176328/( 37,(17 68 /(
e ,
(17
PM-Ertapenem-FR
Pg. 2
PM-Ertapenem-FR
Pg. 3
(U
SpQHP SRULQMHF LRQ
3
H
GH
,QIHF LRQV SHOYLHQQHV DLJXsV
FRPSULV O HQGRP RPp UL H GXSRV SDU XP O DYRU HPHQ
VHS LTXH H
OHV LQIHF LRQV J QpFRORJLTXHVSRV RSpUD RLUHV FDXVpHV SDU6 UHSRFRFF V
F LH
(VFKHULFKL
FRL
3HS RV UHSRFRFF V VSS
F HURLGHV IULLV
3RUSK URPRQ V
VFFK UR
LF
RX3UH R H
VSS
3RXU UpGXLUH O¶DSSDULWLRQ GH EDFWpULHV SKDUPDFRUpVLVWDQWHV HWSRXU
PDLQWHQLU O¶HIILFDFLWp G¶(UWDSpQHP
SRXU LQMHFWLRQ HW GHV DXWUHVPpGLFDPHQWV DQWLEDFWpULHQV (UWDSpQHPSRXU
LQMHFWLRQ GRLWrWUHXWLOLVp
XQLTXHPHQW SRXUWUDLWHUOHV LQIHFWLRQV SRXU OHVTXHOOHV LOHVW GpPRQWUp RX
IRUWHPHQW SUpVXPp TXH GHV
EDFWpULHV VHQVLEOHV HQVRQWOD FDXVH /RUVTXH GHV UHQVHLJQHPHQWV
FRQFHUQDQW OHVFXOWXUHV HW OD
VHQVLELOLWp VRQWGLVSRQLEOHV LOIDXW HQWHQLU FRPSWH SRXU FKRLVLU RX
PRGLILHUXQWUDLWHPHQW
DQWLEDFWpULHQ (Q O¶DEVHQFH GH WHOOHV GRQQpHV OHV SURILOV ORFDX[
G¶pSLGpPLRORJLH HWGH VHQVLELOLWp
SHXYHQW FRQWULEXHU DXFKRL[HPSLULTXH GXWUDLWHPHQW
2QGRLW SUpOHYHU GHVpFKDQWLOORQV DSSURSULpV
HQYXHGHVWHVWVEDFWpULRORJLTXHV SHUPHWWDQWG¶LVROHU
HWG¶LGHQWLILHU OHV PLFUR RUJDQLVPHV UHVSRQVDEOHVGHO¶LQIHFWLRQHW
GHGpWHUPLQHUOHXU VHQVLELOLWp
jO¶HUWDSpQHP2QSHXW LQVWDXUHU XQWUDLWHPHQW LQLWLDOHPSLULTXHDX PR HQ
G¶(UWDSpQHP SRXU
LQMHFWLRQ GDQVOHV FDVG¶LQIHFWLRQ EDFWpULHQQH
FRPSULVOHVLQIHFWLRQV PL[WHV HQDWWHQGDQW OHV
UpVXOWDWV GHVWHVWV EDFWpULRORJLTXHV /H WUDLWHPHQW DQWLPLFURELHQ GRLW
HQVXLWH rWUHDMXVWp VHORQOHV
UpVXOWDWVGHFHVWHVWV
3UpYHQLRQ
(UWDSpQHP
SRXULQMHFWLRQHVWLQGLT